Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Stroopinsky · SciRah

Researcher profile · Semantic Scholar

D. Stroopinsky

Share profile

D. Stroopinsky — researcher profile on SciRah

h-index: 21
Works: 92
Citations: 1,753

Most-cited papers

MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia.
A. Pyzer, D. Stroopinsky, H. Rajabi, Abigail Washington +20 more
2017Blood166 citations Open access
Semantic Scholar
Lenalidomide enhances anti-myeloma cellular immunity
K. Luptakova, J. Rosenblatt, Brett E Glotzbecker, Heidi Mills +11 more
2012Cancer Immunology and Immunotherapy157 citations Open access
Semantic Scholar
Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions
J. Rosenblatt, R. Stone, L. Uhl, D. Neuberg +23 more
2016Science Translational Medicine155 citations Open access
Semantic Scholar
Epstein−Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas
E. Anastasiadou, D. Stroopinsky, Stella Alimperti, Alan L Jiao +16 more
2018Leukemia146 citations Open access
Semantic Scholar
Cobomarsen, an Oligonucleotide Inhibitor of miR-155, Slows DLBCL Tumor Cell Growth In Vitro and In Vivo
E. Anastasiadou, A. Seto, Xuan Beatty, M. Hermreck +10 more
2020Clinical Cancer Research133 citations Open access
Semantic Scholar
Combining a CAR and a chimeric costimulatory receptor enhances T cell sensitivity to low antigen density and promotes persistence
A. Katsarou, Maria Sjöstrand, J. Naik, J. Mansilla-Soto +20 more
2021Science Translational Medicine113 citations Open access
Semantic Scholar
MUC1 inhibition leads to decrease in PD-L1 levels via upregulation of miRNAs
A. Pyzer, D. Stroopinsky, J. Rosenblatt, E. Anastasiadou +23 more
2017Leukemia67 citations Open access
Semantic Scholar
Rituximab-induced direct inhibition of T-cell activation
D. Stroopinsky, T. Katz, J. Rowe, D. Melamed +1 more
2012Cancer Immunology and Immunotherapy67 citations
Semantic Scholar
Dynamic analysis of immune and cancer cell interactions at single cell level in microfluidic droplets.
Saheli Sarkar, Pooja Sabhachandani, D. Stroopinsky, Kristen Palmer +4 more
2016Biomicrofluidics64 citations Open access
Semantic Scholar
Hypomethylating agent alters the immune microenvironment in AML and enhances the immunogenicity of a DC/AML vaccine
M. Nahas, D. Stroopinsky, J. Rosenblatt, L. Cole +17 more
2019British Journal of Haematology61 citations Open access
Semantic Scholar
Anti-CD20 monoclonal antibodies: beyond B-cells.
I. Avivi, D. Stroopinsky, T. Katz
2013Blood reviews58 citations
Semantic Scholar
MUC1 IS A POTENTIAL TARGET FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA STEM CELLS
D. Stroopinsky, J. Rosenblatt, Keisuke Ito, Heidi Mills +15 more
2013Cancer Research51 citations Open access
Semantic Scholar
MUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemia
Ashujit Tagde, H. Rajabi, D. Stroopinsky, R. Gali +6 more
2016OncoTarget45 citations Open access
Semantic Scholar
Mucin 1 is a potential therapeutic target in cutaneous T-cell lymphoma.
Salvia Jain, D. Stroopinsky, L. Yin, J. Rosenblatt +14 more
2014Blood36 citations Open access
Semantic Scholar
MUC1 in hematological malignancies
D. Stroopinsky, D. Kufe, D. Avigan
2016Leukemia and Lymphoma35 citations Open access
Semantic Scholar
Phase 1 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease.
M. Nahas, R. Soiffer, Haesook T. Kim, E. Alyea +23 more
2016Blood35 citations
Semantic Scholar
Vulnerabilities in mIDH2 AML confer sensitivity to APL-like targeted combination therapy
V. Mugoni, Riccardo Panella, Giulia Cheloni, Ming Chen +18 more
2019Cell Research33 citations Open access
Semantic Scholar
Allogeneic induced human FOXP3+IFN‐γ+ T cells exhibit selective suppressive capacity
D. Stroopinsky, I. Avivi, J. Rowe, D. Avigan +1 more
2009European Journal of Immunology31 citations Open access
Semantic Scholar
Leukemia vaccine overcomes limitations of checkpoint blockade by evoking clonal T-cell responses in a murine acute myeloid leukemia model
D. Stroopinsky, J. Liegel, M. Bhasin, Giulia Cheloni +20 more
2021Haematologica29 citations Open access
Semantic Scholar
Bone marrow stroma protects myeloma cells from cytotoxic damage via induction of the oncoprotein MUC1
M. Bar-Natan, D. Stroopinsky, K. Luptakova, M. Coll +14 more
2017British Journal of Haematology28 citations Open access
Semantic Scholar
Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401
D. Chung, N. Shah, Juan Wu, B. Logan +35 more
2023Clinical Cancer Research26 citations Open access
Semantic Scholar
DCOne as an Allogeneic Cell-based Vaccine for Multiple Myeloma
R. Leaf, D. Stroopinsky, A. Pyzer, A. Kruisbeek +12 more
2017Journal of immunotherapy19 citations
Semantic Scholar
MUC1-C oncoprotein promotes FLT3 receptor activation in acute myeloid leukemia cells.
Sui-Yang Liu, L. Yin, D. Stroopinsky, H. Rajabi +6 more
2014Blood19 citations Open access
Semantic Scholar
A Phase I Study of Lenalidomide plus Chemotherapy with Mitoxantrone, Etoposide, and Cytarabine for the Reinduction of Patients with Acute Myeloid Leukemia
D. DeAngelo, A. Brunner, L. Werner, D. Avigan +15 more
2017American journal of hematology/oncology15 citations Open access
Semantic Scholar
MUC1‐C drives myeloid leukaemogenesis and resistance to treatment by a survivin‐mediated mechanism
D. Stroopinsky, H. Rajabi, M. Nahas, J. Rosenblatt +17 more
2018Journal of Cellular and Molecular Medicine14 citations Open access
Semantic Scholar
Decitabine Priming Enhances Mucin 1 Inhibition Mediated Disruption of Redox Homeostasis in Cutaneous T-cell Lymphoma
Salvia Jain, Abigail Washington, R. Leaf, P. Bhargava +11 more
2016Molecular Cancer Therapeutics14 citations Open access
Semantic Scholar
Personalized tumor vaccine for pancreatic cancer
Shira Orr, Ling Huang, James A. Moser, D. Stroopinsky +12 more
2022Cancer Immunology and Immunotherapy13 citations
Semantic Scholar
A subset of CD8+ T cells acquiring selective suppressive properties may play a role in GvHD management.
I. Avivi, D. Stroopinsky, J. Rowe, T. Katz
2013Transplant Immunology12 citations
Semantic Scholar
Lenalidomide Decreases PD-1 Expression, Depletes Regulatory T-Cells and Improves Cellular Response to a Multiple Myeloma/Dendritic Cell Fusion Vaccine In Vitro
K. Luptakova, Brett E Glotzbecker, Heidi Mills, D. Stroopinsky +4 more
201011 citations
Semantic Scholar
Clinical Trial Evaluating DC/AML Fusion Cell Vaccination In AML Patients
R. Stone, L. Uhl, D. Neuberg, B. Vasir +16 more
20139 citations
Semantic Scholar
Phase II clinical trial evaluating Abatacept in patients with steroid-refractory chronic graft versus host disease.
Anita G. Koshy, Haesook T. Kim, J. Liegel, J. Arnason +19 more
2023Blood8 citations Open access
Semantic Scholar
Phase I/Ib Trial of the MUC1 Inhibitor GO-203-2C Alone and in Combination with Decitabine for Acute Myeloid Leukemia
J. Liegel, J. Rosenblatt, R. Stone, Malgorzata McMasters +19 more
20176 citations
Semantic Scholar
DC/Aml Fusion Cell Vaccination Administered to AML Patients Who Achieve a Complete Remission Potently Expands Leukemia Reactive T Cells and Is Associated with Durable Remissions
J. Rosenblatt, R. Stone, L. Uhl, D. Neuberg +17 more
20156 citations
Semantic Scholar
Subasumstat, a first-in-class inhibitor of SUMO-activating enzyme, demonstrates dose-dependent target engagement and SUMOylation inhibition, leading to rapid activation of innate and adaptive immune responses in the dose escalation portion of a phase 1/2 clinical study
G. Saggu, D. Stroopinsky, A. Dudek, A. Olszanski +16 more
2022European Journal of Cancer5 citations Open access
Semantic Scholar
Potent Synergy between Combination of Chimeric Antigen Receptor (CAR) Therapy Targeting CD19 in Conjunction with Dendritic Cell (DC)/Tumor Fusion Vaccine in Hematological Malignancies
M. Capelletti, J. Liegel, M. Themeli, T. Mutis +15 more
2019Blood5 citations Open access
Semantic Scholar
Development of Novel Second Generation DC/Tumor Fusion Vaccine in Lymphoma
Shira Orr, M. Capelletti, Haider Ghiasuddin, D. Stroopinsky +13 more
2019Biology of Blood and Marrow Transplantation4 citations Open access
Semantic Scholar
Clinical Trial Evaluating DC/AML Fusion Cell Vaccination in AML Patients Who Achieve a Chemotherapy-Induced Remission
J. Rosenblatt, R. Stone, L. Uhl, D. Neuberg +17 more
20144 citations Open access
Semantic Scholar
Clinical Trial Evaluating DC/AML Fusion Cell Vaccination Alone and in Conjunction with PD-1 Blockade in AML Patients Who Achieve a Chemotherapy-Induced Remission
J. Rosenblatt, R. Stone, I. Avivi, L. Uhl +26 more
20114 citations Open access
Semantic Scholar
Targeting Acute Myeloid Leukemia Stem Cells by MUC1-C Subunit Inhibition
D. Stroopinsky, J. Rosenblatt, Keisuke Ito, Yin Li +15 more
20104 citations
Semantic Scholar
Vaccine-educated T cells and a CD123 bispecific T-cell engager for treatment of acute myeloid leukemia
J. Liegel, D. Stroopinsky, Giulia Cheloni, Dimitra Karagkouni +20 more
2025Blood Advances3 citations Open access
Semantic Scholar
Synergism between CAR-T Cells and a Personalized Tumor Vaccine in Hematological Malignances
Giulia Cheloni, M. Capelletti, Daniela Torres, P. Bindal +14 more
2021Blood3 citations Open access
Semantic Scholar
Potent Synergy between Combination of Chimeric Antigen Receptor (CAR) Therapy Targeting CD19 in Conjunction with Dendritic Cell (DC)/Tumor Fusion Vaccine in Hematological Malignancies.
M. Capelletti, J. Liegel, M. Themeli, T. Mutis +14 more
20203 citations Open access
Semantic Scholar
Correction: Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401
David J. Chung, Nina Shah, Juan Wu, Brent Logan +36 more
2024Clinical Cancer Research2 citations
Semantic Scholar
Abstract CT061: Pharmacodynamic analysis from a phase 1/2 study of subasumstat (TAK-981) as single agent in patients (pts) with advanced/refractory metastatic solid tumors
D. Stroopinsky, Slawomir Mandzuik, Daniel Anderson, J. Hernandez-rivas +13 more
2024Cancer Research2 citations
Semantic Scholar
Randomized Phase II Trial of Dendritic Cell/AML Fusion Cell Vaccination Compared to Standard of Care Therapy in AML CR1
Prateek Pophali, Giulia Cheloni, Richard M. Stone, Kai W. Wucherpfennig +28 more
2024Blood2 citations
Semantic Scholar
Phase II Clinical Trial of Abatacept for Steroid-Refractory Chronic Graft Versus Host Disease
Anita G. Koshy, Haesook T. Kim, D. Stroopinsky, J. Liegel +16 more
2021Blood2 citations Open access
Semantic Scholar
Impact of Autologous Hematopoietic Cell Transplant (HCT) Followed By Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance in Increasing Multiple Myeloma (MM) Immunity (BMT CTN 1401)
D. Chung, N. Shah, D. Stroopinsky, Juan Wu +33 more
2021Blood2 citations Open access
Semantic Scholar
CD155-Tigit Pathway Modulation in Dendritic Cell/Acute Myeloid Leukemia Fusion Vaccine Model
M. Nahas, D. Stroopinsky, M. Capelletti, J. Rosenblatt +6 more
2019Blood2 citations
Semantic Scholar
A Novel Monoclonal Antibody Combination Plus DC/AML Fusion Vaccine Eradicates AML in an Immunocompetent Murine Model
D. Stroopinsky, J. Liegel, K. Mahoney, J. Rosenblatt +14 more
2018Blood2 citations Open access
Semantic Scholar
Bone Marrow Stroma Protects Myeloma Cells from Cytotoxic Damage Via Induction of the Oncoprotein MUC1
M. Bar-Natan, K. Luptakova, M. Coll, D. Stroopinsky +12 more
20142 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Rosenblatt×37
Invite
J. Rosenblatt — researcher profile on SciRah
D. Avigan×28
Invite
D. Avigan — researcher profile on SciRah
D. Kufe×27
Invite
D. Kufe — researcher profile on SciRah
J. Arnason×18
Invite
J. Arnason — researcher profile on SciRah

×17

Invite

D. Avigan — researcher profile on SciRah

Invite

M. Nahas — researcher profile on SciRah

Salvia Jain×15

Invite

Salvia Jain — researcher profile on SciRah

Invite

R. Joyce — researcher profile on SciRah

Invite

R. Stone — researcher profile on SciRah

Invite

J. Liegel — researcher profile on SciRah

K. Luptakova×13

Invite

K. Luptakova — researcher profile on SciRah

Invite

A. Pyzer — researcher profile on SciRah